As there is a wide range of different specific mutations with a range of disease severity in CMT1B and CMT1X, it is possible that patients with specific mutations within these subtypes may prove to have elevated TMPRSS5 levels. This evidence concerns the gene TMPRSS5 and X-linked Charcot-Marie-Tooth disease type 1.